Beximco Pharms Usa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BEXIMCO PHARMS USA, and what generic and branded alternatives to BEXIMCO PHARMS USA drugs are available?
BEXIMCO PHARMS USA has eighteen approved drugs.
Drugs and US Patents for Beximco Pharms Usa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beximco Pharms Usa | ELETRIPTAN HYDROBROMIDE | eletriptan hydrobromide | TABLET;ORAL | 215467-002 | Jul 13, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Beximco Pharms Usa | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET;ORAL | 213550-001 | Jul 14, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Beximco Pharms Usa | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | TABLET;ORAL | 207428-003 | Oct 21, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.